Upadacitinib for Prurigo Nodularis

NCT06773403 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Prurigo Nodularis

Interventions

DRUG: Upadacitinib

Sponsor

Psoriasis Treatment Center of Central New Jersey

Collaborators

[object Object]